Olymvax
Chengdu
About Olymvax
Olymvax is a biopharmaceutical firm that develops, manufactures, and sells human vaccinations. They are integrating global resources, maintaining cooperation with all parties, and striving to develop technological innovation for the development of vaccines. Their products include the tetanus vaccine and the Haemophilus influenzae B vaccine.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Total funding: $8.7M
- Funding stage: IPO
- Last round: Post-IPO Equity (May 2017)
- Ticker: neeq:833577
- Website: olymvax.com
- Phone: 86-28-69361111
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical, Sales
Social Profiles
Canonical: https://fsome.com/organization/olymvax-2213807 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.